Kevin K. Dobbin

Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia

Richard C. Harvey, Charles G. Mullighan, I‐Ming Chen et al. · Blood · 2010 · 569 citations · Full text

Optimally splitting cases for training and testing high dimensional classifiers

Kevin K. Dobbin, Richard Simon · BMC Medical Genomics · 2011 · 407 citations · Full text

Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome

Richard C. Harvey, Charles G. Mullighan, Xuefei Wang et al. · Blood · 2010 · 404 citations · Full text

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

Janet Dancey, Kevin K. Dobbin, Susan Groshen et al. · Clinical Cancer Research · 2010 · 254 citations · Full text

Biomarker Studies, Novel Agents, Biomarker (Medicine) +17

Interlaboratory Comparability Study of Cancer Gene Expression Analysis Using Oligonucleotide Microarrays

Kevin K. Dobbin, David G. Beer, Matthew Meyerson et al. · Clinical Cancer Research · 2005 · 181 citations · Full text